Dr Carlos Miguel D'assumpcao, MD | |
1700 Mount Vernon Ave, Bakersfield, CA 93306-4018 | |
(661) 326-2202 | |
(661) 326-2950 |
Full Name | Dr Carlos Miguel D'assumpcao |
---|---|
Gender | Male |
Speciality | Internal Medicine - Infectious Disease |
Location | 1700 Mount Vernon Ave, Bakersfield, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053806067 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | A173741 (California) | Primary |
Entity Name | Kern County Hospital Authority |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376623538 PECOS PAC ID: 4688964521 Enrollment ID: O20160915002690 |
News Archive
Male and female serial killers tend to choose their victims and commit their crimes in different ways, which may be due to thousands of years of psychological evolution, according to researchers.
BioLineRx Ltd., a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today it has in-licensed BL-1110, a novel compound for the treatment of neuropathic pain.
Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.
Today's headlines include news coverage of yesterday's update from the Obama administration regarding the number of people who have enrolled in private health insurance through the health law's online marketplaces.
Amylin Pharmaceuticals, Inc. today announced that it has submitted the initial sections of a rolling submission for a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the use of metreleptin to treat diabetes and/or hypertriglyceridemia (high levels of triglycerides in the bloodstream) in patients with rare forms of lipodystrophy.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Carlos Miguel D'assumpcao, MD 1700 Mount Vernon Ave, Bakersfield, CA 93306-4018 Ph: (661) 326-2202 | Dr Carlos Miguel D'assumpcao, MD 1700 Mount Vernon Ave, Bakersfield, CA 93306-4018 Ph: (661) 326-2202 |
News Archive
Male and female serial killers tend to choose their victims and commit their crimes in different ways, which may be due to thousands of years of psychological evolution, according to researchers.
BioLineRx Ltd., a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today it has in-licensed BL-1110, a novel compound for the treatment of neuropathic pain.
Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.
Today's headlines include news coverage of yesterday's update from the Obama administration regarding the number of people who have enrolled in private health insurance through the health law's online marketplaces.
Amylin Pharmaceuticals, Inc. today announced that it has submitted the initial sections of a rolling submission for a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the use of metreleptin to treat diabetes and/or hypertriglyceridemia (high levels of triglycerides in the bloodstream) in patients with rare forms of lipodystrophy.
› Verified 6 days ago
Marsha Cheng, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2400 Wible Rd Ste 14, Bakersfield, CA 93304 Phone: 661-835-1240 Fax: 661-835-4667 | |
Sarah Dowda, NP Infectious Disease Medicare: Medicare Enrolled Practice Location: 8327 Brimhall Rd Ste 704, Bakersfield, CA 93312 Phone: 661-829-7677 Fax: 661-679-6920 | |
Peter Alagona Jr., M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 5020 Commerce Dr, Bakersfield, CA 93309 Phone: 661-324-4100 Fax: 661-324-4600 | |
Paramvir Singh Rahal, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9802 Stockdale Hwy, Ste 102, Bakersfield, CA 93311 Phone: 661-323-1200 Fax: 661-616-5339 | |
Harieet Singh, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2415 Niles St, Bakersfield, CA 93306 Phone: 661-631-1591 Fax: 661-631-1594 | |
Bruce G Dains, PAC Infectious Disease Medicare: Medicare Enrolled Practice Location: 2701 Chester Ave, Highgrove Medical Center, Bakersfield, CA 93301 Phone: 661-326-1600 Fax: 661-323-2307 | |
Dr. Oscar W. Rico, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 9001 Stockdale Hwy, 28 Hc, Bakersfield, CA 93311 Phone: 661-654-2395 |